Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences

Figure 5

In vivo inhibition of heterotopic tumors in response to H19-DTA-P4-DTA treatments. Inhibition of tumor growth in response to H19-DTA, P4-DTA, or H19-DTA-P4-DTA treatments is shown. The tumor sizes of tumors treated with the DTA expressing vector, or with control luciferase expressing vectors were determined prior to each treatment and before sacrifice. The fold increase in tumor volume was calculated relative to the initial volume at the day of the first treatment.

Back to article page